Paydirt
SVRA
Ticker

Savara Inc.

SVRA · Healthcare · Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States

Savara Inc. (SVRA), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 0 purchases and 2 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Jun 22 and filed Jun 22. The most active filer was David A Ramsay with 3 filings.

Add to watchlist
Filings, ttm
2
0 buys · 2 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$2.4M
estimated for Congress, as filed for insiders
Median delay
0d
execution to disclosure
Last traded
Jun 22
Filed Jun 22
ADViAverage daily dollar volume
$9.6M
market data
Share price · 12M
$5.50 (+57.6%)
$6.94$5.15$3.37Sep 22 2025Feb 27Aug 5

Adjusted for splits and dividends.

Volume by month
$2.2M$1.1M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · buys $288KDec 2024 · sells $181KApr 2025 · buys $417KDec 2025 · sells $121KJun 2026 · sells $2.2M
Buys $705K Sells $2.5M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
DR David A Ramsay Director 3 filings DL David L Lowrance Chief Financial Officer 1 filing MP Matthew Pauls Director 1 filing
Recent filings
David L LowranceSALE Chief Financial Officer $2.2M
394,528 sh × $5.68
Exec Jun 22
Filed Jun 22 · 5:30 PM ET David A RamsaySALE Director $121K
20,000 sh × $6.06
Exec Dec 19 2025
Filed Dec 19 2025 · 5:30 PM ET David A RamsayPURCHASE Director $417K
150,000 sh × $2.78
Exec Mar 31 2025
Filed Apr 1 2025 · 5:30 PM ET Matthew PaulsSALE CHIEF EXECUTIVE OFFICER $181K
54,702 sh × $3.31
Exec Dec 16 2024
Filed Dec 16 2024 · 5:30 PM ET David A RamsayPURCHASE Director $288K
100,000 sh × $2.88
Exec Nov 18 2024
Filed Nov 18 2024 · 5:30 PM ET